VITARIA Registry Study

Exclusion Criteria

• •1. Hospitalization for heart failure and/or required the use of Heart Failure intravenous therapy in the past 30 days
• •2. Severe mitral and/or any aortic valve dysfunction
• •3. History of acute coronary syndrome (ACS) in the past 90 days
• •4. Stroke or transient ischemic attack (TIA) in the past 90 days
• •5. Coronary Artery Bypass Surgery (CABG) in the past 90 days
• •6. PCI in the past 90 days
• •7. Surgery for Valve replacement (Aortic or mitral valve) in the past 90 days
• •8. Left ventricular end diastolic diameter (LVEDD) \> 80 mm
• •9. Patients who have had a cardiac resynchronization therapy (CRT) device implanted and have been actively treated with CRT for \< 12 months
• •10. Patients that are scheduled for CRT
• •11. Patients who are listed for heart transplant or expected to be candidates for heart transplant
• •12. Patients on hemodialysis or peritoneal dialysis
• •13. Patients with diabetes (type I or type II) that is being medically treated for autonomic or sensory neuropathy, or measured hemoglobin A1c (HbA1c) above 8.0% in the past 3 months